CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coppock, D. L.
Right arrow Articles by Nathanson, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coppock, D. L.
Right arrow Articles by Nathanson, L.

Cell Growth & Differentiation, Vol 3, Issue 8 485-494, Copyright © 1992 by American Association of Cancer Research


ARTICLES

12-O-tetradecanoylphorbol-13-acetate induces transient cell cycle arrest in G1 and G2 in metastatic melanoma cells: inhibition of phosphorylation of p34cdc2

DL Coppock, JB Tansey and L Nathanson
Oncology Research Laboratory, Winthrop University Hospital, Mineola, New York 11501.

The growth of Demel human metastatic melanoma cells was inhibited by 12-O-tetradecanoylphorbol-13-acetate (TPA) and other nonphorbol tumor promoters including palytoxin and okadaic acid. Using flow cytometry, we have demonstrated that the cells arrested growth in G1 and G2 phases of the cell cycle. Detailed analysis of the kinetics of the growth arrest in unsynchronized cells showed that (a) the growth arrest was transient and peaked 16-20 h following addition of TPA; (b) effects of TPA on cell growth began within 1-2 h after the addition; and (c) cells completed S phase and arrested in G2. In addition, TPA induced a pronounced morphological change, which peaked by 1 h and gradually subsided over 24 h. In populations of cells synchronized in G1 using lovastatin, (a) addition of TPA blocked the onset of DNA synthesis up to the end of G1; (b) the lag between addition of the drug and onset of DNA synthesis was less than 30 min; and (c) addition of TPA at the end of G1 prevented the increased phosphorylation of p34cdc2, as determined by immunoprecipitation. The experiments reported here show that TPA transiently blocked the proliferation of Demel melanoma cells at the G1-S border and in G2, thus preventing cells from progressing through the cell cycle. These experiments suggest that pathways involving protein kinase C interact with and rapidly alter the molecular pathways involving p34cdc2 which regulate the onset of DNA synthesis and the G2-M transition.


This article has been cited by other articles:


Home page
J Biol ChemHome page
H. S. Kim and I. K. Lim
Phosphorylated Extracellular Signal-regulated Protein Kinases 1 and 2 Phosphorylate Sp1 on Serine 59 and Regulate Cellular Senescence via Transcription of p21Sdi1/Cip1/Waf1
J. Biol. Chem., June 5, 2009; 284(23): 15475 - 15486.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-J. Cozzi, P. G. Parsons, S. M. Ogbourne, J. Pedley, and G. M. Boyle
Induction of Senescence in Diterpene Ester-Treated Melanoma Cells via Protein Kinase C-Dependent Hyperactivation of the Mitogen-Activated Protein Kinase Pathway.
Cancer Res., October 15, 2006; 66(20): 10083 - 10091.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. Y. Lee, Y. A. Hannun, and L. M. Obeid
Functional Dichotomy of Protein Kinase C (PKC) in Tumor Necrosis Factor-{alpha} (TNF-{alpha}) Signal Transduction in L929 Cells: TRANSLOCATION AND INACTIVATION OF PKC BY TNF-{alpha}
J. Biol. Chem., September 22, 2000; 275(38): 29290 - 29298.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. W. Ashton, G. Watanabe, C. Albanese, E. O. Harrington, J. A. Ware, and R. G. Pestell
Protein Kinase C{delta} Inhibition of S-Phase Transition in Capillary Endothelial Cells Involves the Cyclin-dependent Kinase Inhibitor p27Kip1
J. Biol. Chem., July 23, 1999; 274(30): 20805 - 20811.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. R. Frey, M. L. Saxon, X. Zhao, A. Rollins, S. S. Evans, and J. D. Black
Protein Kinase C Isozyme-mediated Cell Cycle Arrest Involves Induction of p21waf1/cip1 and p27kip1 and Hypophosphorylation of the Retinoblastoma Protein in Intestinal Epithelial Cells
J. Biol. Chem., April 4, 1997; 272(14): 9424 - 9435.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Sasaguri, A. Ishida, C. Kosaka, H. Nojima, and J. Ogata
Phorbol Ester Inhibits the Phosphorylation of the Retinoblastoma Protein without Suppressing Cyclin D-associated Kinase in Vascular Smooth Muscle Cells
J. Biol. Chem., April 5, 1996; 271(14): 8345 - 8351.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. Y. Lee, Y. A. Hannun, and L. M. Obeid
Functional Dichotomy of Protein Kinase C (PKC) in Tumor Necrosis Factor-{alpha} (TNF-{alpha}) Signal Transduction in L929 Cells: TRANSLOCATION AND INACTIVATION OF PKC BY TNF-{alpha}
J. Biol. Chem., September 22, 2000; 275(38): 29290 - 29298.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1992 by the American Association of Cancer Research.